Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 2Urogenital Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Genital Neoplasms, Male 1Brain Neoplasms 1

Interventions

Abiraterone Acetate 2onapristone 1olaparib 1abiraterone 1Pluvicto 1EPI-506 1BAY 86-7548 1Androgen Antagonists 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Genital Neoplasms, Male × Adrenal Cortex Hormones × Clear all
NCT05067140 2026-05-05

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Novartis

Phase 1/2 Active not recruiting
152 enrolled
Genitourinary

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡